Liver Diseases pp 799-810 | Cite as

Cardiac Surgery Risks in Liver Dysfunction

  • Grigore Tinica
  • Cristina Furnica
  • Raluca Ozana Chistol


The incidence of chronic liver diseases and cirrhosis is steadily increasing. It is therefore common that patients with advanced liver dysfunction are addressed for cardiac surgery interventions. Risk score models specifically developed for cardiac surgery to assess a patient’s surgical candidacy based on the potential unfavourable outcome fail to include all major factors that may render patients at higher risk for surgery. Advanced liver dysfunction is among the excluded factors and for a cardiac surgeon it is problematic to distinguish patients who may benefit from cardiac surgery from those whose perioperative risk exceeds benefit. Consequently, for patients with advanced liver dysfunction, the operative benefit needs to be carefully weighted after a specific assessment and the therapeutic management adapted to the particular clinical picture of the individual patient. The aims of this chapter are to reveal the impact of the pathophysiological changes induced by advanced liver dysfunction on the surgical and anaesthetic outcomes in cardiac surgery and to outline the particular aspects of the pre, intra and postoperative management used to optimize the outcome in this group of patients.


Advanced liver dysfunction Cirrhosis Cardiac surgery Cardiopulmonary bypass Risk scores Outcome Endovascular treatment 


  1. 1.
    Pimpin L, Cortez-Pinto H, Negro F, Corbould E, Lazarus JV, Webber L, Sheron N, EASL HEPAHEALTH Steering Committee. Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies. J Hepatol. 2018;69(3):718–35.CrossRefGoogle Scholar
  2. 2.
    Shah NL, Intagliata N. Hemostatic abnormalities in patients with liver disease. 2018. Topic updated Aug 06, 2018. Scholar
  3. 3.
    Angeli P, Ginès P, Wong F, Bernardi M, Boyer TD, Gerbes A, Moreau R, Jalan R, Sarin SK, Piano S, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. J Hepatol. 2015;62:968–74.CrossRefGoogle Scholar
  4. 4.
    Ruiz-del-Árbol L, Serradilla R. Cirrhotic cardiomyopathy. World J Gastroenterol. 2015;21(41):11502–21.CrossRefGoogle Scholar
  5. 5.
    Bunchorntavakul C, Chamroonkul N, Chavalitdhamrong D. Bacterial infections in cirrhosis: a critical review and practical guidance. World J Hepatol. 2016;8(6):307–21.CrossRefGoogle Scholar
  6. 6.
    Light RW. New treatment for hepatic hydrothorax? Ann Am Thorac Soc. 2016;13(6):773–4.CrossRefGoogle Scholar
  7. 7.
    Grilo-Bensusan I, Pascasio-Acevedo JM. Hepatopulmonary syndrome: what we know and what we would like to know. World J Gastroenterol. 2016;22(25):5728–41.CrossRefGoogle Scholar
  8. 8.
    Rubin LJ. Portopulmonary hypertension. 2019. Topic updated Jan 22, 2019 Scholar
  9. 9.
    Peck-Radosavljevic M, Angeli P, Cordoba J, Farges O, Valla D. Managing complications in cirrhotic patients. U Eur Gastroenterol J. 2015;3(1):80–94.CrossRefGoogle Scholar
  10. 10.
    An J, Shim JH, Kim SO, Lee D, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS. Prevalence and prediction of coronary artery disease in patients with liver cirrhosis: a registry-based matched case-control study. Circulation. 2014;130(16):1353–62.CrossRefGoogle Scholar
  11. 11.
    Jacob KA, Hjortnaes J, Kranenburg G, de Heer F, Kluin J. Mortality after cardiac surgery in patients with liver cirrhosis classified by the Child-Pugh score. Interact Cardiovasc Thorac Surg. 2015;20(4):520–30.CrossRefGoogle Scholar
  12. 12.
    Diaz GC, Renz JF. Cardiac surgery in patients with end-stage liver disease. J Cardiothorac Vasc Anesth. 2014;28(1):155–62.CrossRefGoogle Scholar
  13. 13.
    Hsieh WC, Chen PC, Corciova FC, Tinica G. Liver dysfunction as an important predicting risk factor in patients undergoing cardiac surgery: a systematic review and meta-analysis. Int J Clin Exp Med. 2015;8(11):20712–21.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Yuan X, Zhang H, Zheng Z, Rao C, Zhao Y, Wang Y, Krumholz HM, Hu S. Trends in mortality and major complications for patients undergoing coronary artery bypass grafting among Urban Teaching Hospitals in China: 2004 to 2013. Eur Heart J Qual Care Clin Outcomes. 2017;3(4):312–8.CrossRefGoogle Scholar
  15. 15.
    Sabry AM, Fouad HA, Hashem A, Khalifa AF. Risk factors in adult patients with chronic hepatitis C virus undergoing cardiac surgery with cardiopulmonary bypass: a prospective study. Res Opin Anesth Intens Care. 2017;4(4):213–25.CrossRefGoogle Scholar
  16. 16.
    Safari S, Motavaf M, Seyed Siamdoust SA, Alavian SM. Hepatotoxicity of halogenated inhalational anesthetics. Iran Red Crescent Med J. 2014;16(9):e20153.CrossRefGoogle Scholar
  17. 17.
    Di Tomasso N, Monaco F, Landoni G. Hepatic and renal effects of cardiopulmonary bypass. Best Pract Res Clin Anaesthesiol. 2015;29(2):151–61.CrossRefGoogle Scholar
  18. 18.
    Alqahtani F, Aljohani S, Ghabra A, Alahdab F, Kawsara A, Holmes DR, Alkhouli M. Outcomes of transcatheter versus surgical aortic valve implantation for aortic stenosis in patients with hepatic cirrhosis. Am J Cardiol. 2017;120(7):1193–7.CrossRefGoogle Scholar
  19. 19.
    Yassin AS, Subahi A, Abubakar H, Akintoye E, Alhusain R, Adegbala O, Ahmed A, Elmoughrabi A, Subahi E, Pahuja M, Sahlieh A, Elder M, Kaki A, Schreiber T, Mohamad T. Outcomes and effects of hepatic cirrhosis in patients who underwent transcatheter aortic valve implantation. Am J Cardiol. 2018;122(3):455–60.CrossRefGoogle Scholar
  20. 20.
    Chacon MM, Schulte TE. Liver dysfunction in cardiac surgery - what causes it and is there anything we can do? J Cardiothorac Vasc Anesth. 2018;32(4):1719–21.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Grigore Tinica
    • 1
    • 2
  • Cristina Furnica
    • 2
    • 3
  • Raluca Ozana Chistol
    • 1
    • 2
  1. 1.Cardiovascular InstituteIasiRomania
  2. 2.Grigore T. Popa University of Medicine and PharmacyIasiRomania
  3. 3.Institute of Forensic MedicineIasiRomania

Personalised recommendations